​

Firefly Neuroscience Stock (NASDAQ:AIFF)

RevenueOwnershipFinancialsChart
Firefly Neuroscience by TradingView

Previous Close

$2.77

52W Range

$1.86 - $17.20

50D Avg

$2.81

200D Avg

$3.47

Market Cap

$38.16M

Avg Vol (3M)

$2.57M

Beta

2.03

Div Yield

-

AIFF Company Profile

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

Show More

Industry

Software - Application

Sector

Technology

Exchange

NASDAQ

ADR

-

Country

CA

Employees

13

IPO Date

Nov 28, 2002

Website

AIFF Performance

AIFF Financial Summary

Dec 24Dec 23Dec 22
Revenue$108.00K$498.00K-
Operating Income$-10.05M$-3.08M$-3.33M
Net Income$-10.46M$-2.60M$-3.79M
EBITDA$-10.32M$-2.58M$-3.20M
Basic EPS-$-0.33$-0.48
Diluted EPS-$-0.33$-0.48

Fiscal year ends in Dec 24 | Currency in USD